Xenon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $7,500 | $2,516 | $0 |
Gross Profit | -632 | 7,500 | 1,258 | -669 |
EBITDA | -93,597 | -72,738 | -76,844 | -73,007 |
EBIT | -94,229 | -73,397 | -77,477 | -73,676 |
Net Income | -84,706 | -65,047 | -65,685 | -62,790 |
Net Change In Cash | 0 | 7,500 | 2,516 | 0 |
Free Cash Flow | -64,390 | -61,695 | -55,168 | -51,737 |
Cash | 135,381 | 116,657 | 142,712 | 87,621 |
Basic Shares | 78,953 | 78,687 | 78,386 | 77,926 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $9,434 | $18,437 |
Gross Profit | -2,560 | -167,512 | 9,434 | 18,437 |
EBITDA | -235,859 | -210,513 | -127,519 | -78,087 |
EBIT | -238,419 | -214,054 | -129,143 | -78,993 |
Net Income | -234,330 | -182,393 | -125,373 | -78,882 |
Net Change In Cash | 0 | 0 | 9,434 | 18,437 |
Cost of Revenue | -115,962 | 131,271 | ||
Free Cash Flow | -184,464 | -150,944 | -101,324 | -71,552 |
Cash | 142,712 | 148,643 | 57,242 | 175,688 |
Basic Shares | 77,894 | 66,889 | 60,542 | 43,627 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $1.07 |
2025-03-31 | -$0.83 |
2024-12-31 | -$0.84 |
